Clinical Trials

250 enrolled 13 charts

Breast Neoplasms

NCT03820830 2026-04-09

POLAR

405 enrolled

Breast Cancer Recurrent

NCT02445391 2026-04-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

415 enrolled 15 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00003140 2026-03-27

Letrozole After Tamoxifen in Treating Women With Breast Cancer

5,187 enrolled

Breast Neoplasms

NCT03233191 2026-03-23

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

108,508 enrolled

Breast Screening

NCT01349322 2026-03-05

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

2,354 enrolled 29 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01674140 2026-02-10

e3

1,939 enrolled 15 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00066690 2026-02-06

SOFT

3,066 enrolled 15 charts

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

2,672 enrolled 14 charts

Breast Neoplasms

NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

2,400 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

491 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT03425838 2025-09-19

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

1,050 enrolled

Breast Neoplasm Female

NCT05856773 2025-09-09

COMPRO

276 enrolled

Breast Neoplasms

NCT05512364 2025-08-19

TREAT ctDNA

220 enrolled

Breast Neoplasms

NCT00070564 2025-07-31

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

3,294 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01526369 2025-05-09

TH V THL

75 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms

NCT06407401 2024-11-05

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

399 enrolled

Breast Neoplasms, Musculoskeletal Pain, Drug-Related Side Effects and Adverse Reactions

NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

BreastGenitourinaryThoracic

261 enrolled 12 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT03281954 2024-04-08

Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

1,550 enrolled

Triple Negative Breast Neoplasms

NCT00382070 2024-03-22

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Phase 3 Unknown

3,966 enrolled 12 charts

Breast Neoplasms

NCT00003782 2024-03-21

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

5,351 enrolled 8 charts

Breast Neoplasms

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

1,803 enrolled 20 charts

Breast Neoplasms

NCT01101438 2023-09-13

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

3,649 enrolled 17 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00066573 2023-08-25

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer

7,576 enrolled 10 charts

Breast Neoplasms

NCT00083174 2023-08-25

ExCel

4,560 enrolled 16 charts

Breast Neoplasms

NCT00754845 2023-08-25

Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy

1,918 enrolled 14 charts

Breast Neoplasms

NCT00309478 2023-06-29

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

1,099 enrolled

Breast Neoplasms

NCT00003010 2023-06-15

Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

334 enrolled

Breast Neoplasms

NCT00003519 2023-06-15

Combination Chemotherapy in Treating Women With Breast Cancer

2,778 enrolled

Breast Neoplasms

NCT00004125 2023-06-15

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Breast Neoplasms

NCT00026286 2023-06-15

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast, Hot Flashes

NCT00028990 2023-06-15

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

722 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT01598298 2022-12-16

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

299 enrolled 10 charts

Breast Neoplasms, Pain

NCT00433589 2022-11-17

MINDACT

6,600 enrolled

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00087178 2022-08-11

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

2,722 enrolled 14 charts

Breast Neoplasms

NCT00003857 2022-05-25

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

636 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

1,613 enrolled

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Phase 3 Unknown

1,871 enrolled

Breast Neoplasms

NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

6,097 enrolled 20 charts

Breast Neoplasms

NCT00004067 2021-04-29

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

2,130 enrolled

Breast Neoplasms

NCT00296010 2021-02-23

CASA

Phase 3 Terminated

77 enrolled

Breast Neoplasms

NCT02137837 2021-01-28

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

Phase 3 Terminated

37 enrolled 16 charts

Breast Neoplasms

NCT00075764 2021-01-13

S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

695 enrolled 15 charts

Breast Neoplasms

NCT00309491 2020-10-19

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

2,021 enrolled

Breast Neoplasms

NCT00309569 2020-10-14

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

429 enrolled

Breast Neoplasms

NCT00014222 2020-10-05

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

2,104 enrolled 11 charts

Breast Neoplasms

NCT00625898 2020-09-10

BETH

Phase 3 Terminated

3,509 enrolled

Breast Neoplasms

NCT00354302 2020-04-02

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

497 enrolled

Breast Neoplasms, Osteoporosis

NCT00002542 2020-04-01

Tamoxifen in Treating Women With High-Risk Breast Cancer

672 enrolled